December 2020: BioNTech & Pfizer
On 2 December the first vaccine to prevent Covid-19 is formally approved. The UK Medicines and Healthcare Products Regulatory Agency approved the Pfizer and BioNTech mRNA Covid-19 vaccine for temporary emergency use. The vaccine was found to be over 90 percent effective in the first independent analysis of any Covid-19 vaccine in phase 3 trials (final stage before commercial licensing). Global equity … more